FUJIFILM VisualSonics Launches Vevo F2 LAZR-X20: A Next-Generation Photoacoustic Imaging Platform for Preclinical Research
FUJIFILM VisualSonics Inc., a global leader in high-frequency ultrasound and photoacoustic imaging systems, has officially announced the launch of its latest innovation: the Vevo F2 LAZR-X20 Photoacoustic Imaging Platform. This state-of-the-art system is designed to deliver unparalleled imaging precision and multi-modal functionality for preclinical studies, particularly in small animal research.
The Vevo F2 LAZR-X20 platform integrates intelligent, high-powered laser technology with real-time ultrasound imaging, offering researchers a comprehensive tool for visualizing tissue structures and functions at unmatched resolution and depth. Built on more than two decades of technological leadership in the field, this next-generation platform continues FUJIFILM VisualSonics’ mission to equip the scientific community with cutting-edge imaging capabilities.
Pioneering the Future of Preclinical Imaging
“For more than 20 years, FUJIFILM VisualSonics has been at the forefront of developing high-frequency ultrasound and photoacoustic imaging technologies,” said Greg Nesbitt, Vice President, Global High Frequency, FUJIFILM VisualSonics Inc. “We’ve consistently pushed the boundaries of what researchers can achieve with our systems. With the Vevo LAZR-X20, we’re expanding the scope of research questions that can be addressed—delivering deeper insights and enabling breakthroughs in areas like oncology, cardiovascular research, and neuroscience.”
This new system represents a major leap forward, not just in hardware performance but in the scope and depth of data it can deliver. With enhanced tissue differentiation and functional imaging, researchers can explore complex biological processes in real time.
Intelligent Laser Technology Unlocks Deeper Insights
At the core of the Vevo F2 LAZR-X20 is a powerful, intelligent laser system capable of delivering a broad wavelength range from 660 to 1320 nanometers. This expanded spectral range allows for the detection of specific tissue chromophores—such as lipids, collagen, and hemoglobin—based on their unique light absorption characteristics.
This technology enables non-invasive, label-free imaging of complex tissue environments, including tumor microenvironments and vascular structures. Researchers can now visualize and quantify biological processes such as oxygen saturation, molecular distribution, and therapeutic response with more accuracy and clarity than ever before.
“The advanced laser capabilities allow us to move beyond structural imaging and into the realm of true functional and molecular imaging,” said Andrew Needles, Director of Product Innovation at FUJIFILM VisualSonics. “It’s not just about seeing anatomy anymore—it’s about understanding what’s happening inside the tissue, dynamically and in context.”
A Single, Integrated Platform for Comprehensive Imaging
One of the most notable features of the Vevo F2 LAZR-X20 is its fully integrated system, which combines high-frequency ultrasound and photoacoustic imaging into one unified platform. This allows researchers to simultaneously acquire anatomical, functional, and molecular data without the need for multiple instruments or imaging modalities.
The system’s real-time imaging capabilities, coupled with its high spatial resolution and customizable acquisition protocols, make it ideally suited for a wide range of research areas including:
- Oncology: Visualize tumor vascularization, oxygenation, and drug distribution.
- Neuroscience: Investigate brain activity, stroke models, and neurovascular function.
- Cardiovascular Research: Monitor myocardial perfusion, plaque characterization, and inflammation.
- Drug Development: Evaluate therapeutic efficacy and drug delivery in vivo.
Enabling Breakthroughs Across Scientific Disciplines
The Vevo F2 LAZR-X20 is already being positioned as a transformative tool in the preclinical imaging space. Its ability to deliver high-quality, multi-parameter data in real time will help researchers answer complex biological questions faster and more reliably—potentially accelerating the path from discovery to therapy.
“With the Vevo F2 LAZR-X20, we’re giving scientists a more powerful lens through which to study biology,” said Needles. “This isn’t just an incremental improvement—it’s a platform built to enable groundbreaking research and future innovations.”
Conclusion: Innovation That Drives Discovery
As preclinical research becomes increasingly data-driven and precision-focused, tools like the Vevo F2 LAZR-X20 are essential for advancing the frontiers of biomedical science. FUJIFILM VisualSonics’ latest offering sets a new standard for photoacoustic and ultrasound imaging, providing a flexible, high-performance platform for today’s most demanding research challenges.
